"What" Series

What is a CRO in Life Sciences?

26 September 2023
2 min read

The full name is Contract Research Organization, which is a contract outsourcing service organization for new drug research and development. It primarily provides clinical research services for new drugs to pharmaceutical companies through contracts. A CRO has the ability to quickly assemble a highly specialized clinical research team with extensive experience and can reduce the overall management costs of the pharmaceutical company.

A CRO's work can cover all aspects of new drug research and development and trials. Depending on the different stages of drug development it covers, a CRO can be divided into preclinical CROs and clinical CROs.

A preclinical CRO primarily conducts laboratory studies and live animal studies on candidate drugs obtained from the compound research stage under laboratory conditions. This is done in order to observe the biological activity of the compound on the target disease and to conduct safety evaluations. The main services provided by a preclinical CRO include pharmacology studies, toxicology studies, and animal pharmacokinetic studies. In addition to these, preclinical drug research also includes the synthetic process of the drug, extraction methods, physical and chemical properties and purity, dosage form selection, prescription screening, preparation process, testing methods, quality indicators, stability, pharmacology, toxicology, and animal pharmacokinetic studies. In contrast, a clinical CRO provides outsourcing services for various stages of clinical trials for drugs.

A clinical CRO generally provides clinical trial technology services, on-site management, data management and statistical analysis, for drug clinical trials, including Phase I-IV clinical trials and BE trials. They also provide registration and declaration services.

Analysis on the Research Progress of IL-6 inhibitors
Analysis on the Research Progress of IL-6 inhibitors
26 September 2023
Interleukin-6 (IL-6) is a 26-kDa secretory protein composed of 184 amino acids and two N-glycosylation sites, as well as four cysteine residues in the mature IL-6.
Read →
Orchard Therapeutics Declares Approval of Biologics License Application for OTL-200 pertaining to MLD
Latest Hotspot
3 min read
Orchard Therapeutics Declares Approval of Biologics License Application for OTL-200 pertaining to MLD
26 September 2023
Orchard Therapeutics, a renowned leader in gene therapy worldwide, reported that the U.S. FDA has approved the submission of their BLA for OTL-200.
Read →
Gaining the Competitive Edge: Effective Strategies for Patent Retrieval and Analysis of ADC Drugs
Bio Sequence
2 min read
Gaining the Competitive Edge: Effective Strategies for Patent Retrieval and Analysis of ADC Drugs
26 September 2023
Kadcyla is an antibody-drug conjugate (ADC) used as a single-agent treatment for HER2-positive metastatic breast cancer patients. The article introduces the specific operational methods for patent retrieval of the ADC drug Kadcyla.
Read →
Rani Therapeutics begins Phase 1 trial of RT-111
Latest Hotspot
3 min read
Rani Therapeutics begins Phase 1 trial of RT-111
26 September 2023
Rani Therapeutics Holdings proclaimed the launch of a Phase 1 clinical investigation assessing the safety and tolerability of RT-111.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.